Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q1 2021 (← Previous) (Next →)

Filing Date: May 14, 2021

Total Value ($000): $311,695 (100.0% shares, 0.0% debt)

Holdings (9)

— KARUNA THERAPEUTICS INC 35.1%

Value ($000) $109,254 Shares 908,708 Est. Cost $101.59 Unrealized —

— BOLT BIOTHERAPEUTICS INC 20.0%

Value ($000) $62,248 Shares 1,891,467 Est. Cost $32.91 Unrealized —

— INOZYME PHARMA INC 10.1%

Value ($000) $31,505 Shares 1,591,154 Est. Cost $20.64 Unrealized —

PCVX VAXCYTE INC 8.9%

Value ($000) $27,757 Shares 1,405,421 Est. Cost $37.18 Unrealized -32.3%

— AKOUOS INC 8.0%

Value ($000) $24,884 Shares 1,794,088 Est. Cost $19.83 Unrealized —

— ALIGOS THERAPEUTICS INC 6.4%

Value ($000) $19,933 Shares 876,548 Est. Cost $27.65 Unrealized —

— FUSION PHARMACEUTICALS INC 5.5%

Value ($000) $17,135 Shares 1,598,379 Est. Cost $11.75 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 5.3%

Value ($000) $16,462 Shares 569,041 Est. Cost $24.49 Unrealized +27.5%

— ENTASIS THERAPEUTICS HLDGS I 0.8%

Value ($000) $2,517 Shares 1,176,378 Est. Cost $2.47 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	908,708	$109,254	35.1%	$101.59	—	COM	48576A100
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$62,248	20.0%	$32.91	—	COM	097702104
—	INOZYME PHARMA INC	1,591,154	$31,505	10.1%	$20.64	—	COM	45790W108
PCVX	VAXCYTE INC	1,405,421	$27,757	8.9%	$37.18	-32.3%	COM	92243G108
—	AKOUOS INC	1,794,088	$24,884	8.0%	$19.83	—	COM	00973J101
—	ALIGOS THERAPEUTICS INC	876,548	$19,933	6.4%	$27.65	—	COM	01626L105
—	FUSION PHARMACEUTICALS INC	1,598,379	$17,135	5.5%	$11.75	—	COM	36118A100
ARQT	ARCUTIS BIOTHERAPEUTICS INC	569,041	$16,462	5.3%	$24.49	+27.5%	COM	03969K108
—	ENTASIS THERAPEUTICS HLDGS I	1,176,378	$2,517	0.8%	$2.47	—	COM	293614103